MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

Por Hung, Chao-Hung, Chiu, Yi-Chun, Chen, Chien-Hung, Hu, Tsung-Hui
Publicado em 2014

Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib

Por Kee, Kwong-Ming, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan
Publicado em 2014

Liu-stain quick cytodiagnosis of ultrasound-guided fine needle aspiration in diagnosis of liver tumors

Por Changchien, Chi-Sin, Wang, Jing-Houng, Lu, Sheng-Nan, Hung, Chao-Hung, Chen, Chien-Hung, Lee, Chuan-Mo
Publicado em 2007

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function

Por Chien, Tai-Long, Wang, Jing-Houng, Kee, Kwong-Ming, Chen, Chien-Hung, Hung, Chao-Hung, Lu, Sheng-Nan
Publicado no PLoS One (2016)

Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues

Por Chen, Chien-Hung, Chiu, Yi-Chun, Lu, Sheng-Nan, Lee, Chuan-Mo, Wang, Jing-Houng, Hu, Tsung-Hui, Hung, Chao-Hung
Publicado em 2014

Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients

Por Lee, Chuan-Mo, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung, Yen, Yi-Hao
Publicado no BMC Gastroenterol (2016)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL

Por Yao, Chih-Chien, Hung, Chao-Hung, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Hung, Lee, Chung-Mo, Chen, Chien-Hung
Publicado no Sci Rep (2017)

Is Hepatitis C Virus Core Antigen an Adequate Marker for Community Screening?

Por Kuo, Yuan-Hung, Chang, Kuo-Chin, Wang, Jing-Houng, Tsai, Pei-Shan, Hung, Shu-Feng, Hung, Chao-Hung, Chen, Chien-Hung, Lu, Sheng-Nan
Publicado em 2012

Significance of Vitamin D Receptor Gene Polymorphisms for Risk of Hepatocellular Carcinoma in Chronic Hepatitis C

Por Hung, Chao-Hung, Chiu, Yi-Chun, Hu, Tsung-Hui, Chen, Chien-Hung, Lu, Sheng-Nan, Huang, Chao-Min, Wang, Jing-Houng, Lee, Chuan-Mo
Publicado em 2014

Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C

Por Kuo, Ming-Te, Hu, Tsung-Hui, Lu, Sheng-Nan, Hung, Chao Hung, Wang, Jing-Houng, Chen, Chien-Hung, Chiu, Yi-Chun, Lee, Chuan-Mo
Publicado no Dis Markers (2014)

Clinical Significance of Hepatitis B Virus (HBV) Genotypes and Precore and Core Promoter Mutations Affecting HBV e Antigen Expression in Taiwan

Por Chen, Chien-Hung, Lee, Chuan-Mo, Lu, Sheng-Nan, Changchien, Chi-Sin, Eng, Hock-Liew, Huang, Chao-Min, Wang, Jing-Houng, Hung, Chao-Hung, Hu, Tsung-Hui
Publicado em 2005

Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis

Por Kuo, Yuan-Hung, Lu, Sheng-Nan, Hung, Chao-Hung, Kee, Kwong-Ming, Chen, Chien-Hung, Hu, Tsung-Hui, Lee, Chuan-Mo, Changchien, Chi-Sin, Wang, Jing-Houng
Publicado em 2010

Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin

Por Wang, Jing-Houng, Tung, Hung-Da, Chen, Tai-Yi, Hung, Chao-Hung, Chen, Chien-Hung, Changchien, Chi-Sin, Hu, Tsung-Hui, Lee, Chuan-Mo, Lu, Sheng-Nan
Publicado em 2010

Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study

Por Tsai, Ming-Chao, Chen, Chien-Hung, Tseng, Po-Lin, Hung, Chao-Hung, Chiu, King-Wah, Chang, Kuo-Chin, Yen, Yi-Hao, Lin, Ming-Tsung, Hu, Tsung-Hui
Publicado no PLoS One (2016)

Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection

Por Hung, Chao-Hung, Wang, Jing-Houng, Hu, Tsung-Hui, Chen, Chien-Hung, Chang, Kuo-Chin, Yen, Yi-Hao, Kuo, Yuan-Hung, Tsai, Ming-Chao, Lu, Sheng-Nan, Lee, Chuan-Mo
Publicado em 2010

The Changes of Liver Stiffness and Its Associated Factors for Chronic Hepatitis B Patients with Entecavir Therapy

Por Kuo, Yuan-Hung, Lu, Sheng-Nan, Chen, Chien-Hung, Chang, Kuo-Chin, Hung, Chao-Hung, Tai, Wei-Chen, Tsai, Ming-Chao, Tseng, Po-Lin, Hu, Tsung-Hui, Wang, Jing-Houng
Publicado em 2014

Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment

Por Yeh, Jen-Hao, Hung, Chao-Hung, Wang, Jing-Houng, Chen, Chien-Hung, Kee, Kwong-Ming, Kuo, Chung-Mou, Yen, Yi-Hao, Cheng, Yu-Fan, Chen, Yen-Yang, Hsu, Hsuan-Chi, Lu, Sheng-Nan
Publicado no PLoS One (2015)

Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels

Por Wu, Cheng-Kung, Chang, Kuo-Chin, Tseng, Po-Lin, Lu, Sheng-Nan, Chen, Chien-Hung, Wang, Jing-Houng, Lee, Chuan-Mo, Lin, Ming-Tsung, Yen, Yi-Hao, Hung, Chao-Hung, Hu, Tsung-Hui
Publicado no PLoS One (2016)

Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir

Por Chen, Chien-Hung, Lee, Chuan-Mo, Lai, Hsueh-Chou, Hu, Tsung-Hui, Su, Wen-Pang, Lu, Sheng-Nan, Lin, Chia-Hsin, Hung, Chao-Hung, Wang, Jing-Houng, Lee, Mei-Hsuan, Peng, Cheng-Yuan
Publicado no Oncotarget (2017)

Tenofovir versus Entecavir in Treatment of Chronic Hepatitis B Virus with Severe Acute Exacerbation

Por Hung, Chao-Hung, Hu, Tsung-Hui, Lu, Sheng-Nan, Lee, Chuan-Mo, Chen, Chih-Hung, Kee, Kwong-Ming, Wang, Jing-Houng, Tsai, Ming-Chao, Kuo, Yuan-Hung, Chang, Kuo-Chin, Chiu, Yi-Chun, Chen, Chien-Hung
Publicado no Antimicrob Agents Chemother (2015)